Cristian P Moiola
Overview
Explore the profile of Cristian P Moiola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sengal A, Bonazzi V, Smith D, Moiola C, Lourie R, Rogers R, et al.
NPJ Precis Oncol
. 2023 Dec;
7(1):127.
PMID: 38062117
Endometrial cancer (EC) patients with metastatic/recurrent disease have limited treatment options and poor survival outcomes. Recently, we discovered the FGFR2c splice isoform is associated with poor prognosis in EC patients....
2.
Villafranca-Magdalena B, Masferrer-Ferragutcasas C, Lopez-Gil C, Coll-de la Rubia E, Rebull M, Parra G, et al.
Int J Mol Sci
. 2022 Jun;
23(11).
PMID: 35682944
Endometrial cancer (EC) is the second most frequent gynecological cancer worldwide. Although improvements in EC classification have enabled an accurate establishment of disease prognosis, women with a high-risk or recurrent...
3.
Mota A, Oltra S, Selenica P, Moiola C, Casas-Arozamena C, Lopez-Gil C, et al.
Oncogene
. 2022 Feb;
41(13):1835-1850.
PMID: 35145232
Analyzing different tumor regions by next generation sequencing allows the assessment of intratumor genetic heterogeneity (ITGH), a phenomenon that has been studied widely in some tumor types but has been...
4.
Moiola C, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, et al.
Int J Mol Sci
. 2018 Aug;
19(8).
PMID: 30126113
Endometrial cancer (EC) is the most common malignancy of the genital tract among women in developed countries. Recently, a molecular classification of EC has been performed providing a system that,...
5.
Van Nyen T, Moiola C, Colas E, Annibali D, Amant F
Int J Mol Sci
. 2018 Aug;
19(8).
PMID: 30096949
Endometrial cancer is the most common type of cancer of the female reproductive tract. Although prognosis is generally good for patients with low-grade and early-stage diseases, the outcomes for high-grade...
6.
Devis L, Martinez-Garcia E, Moiola C, Quiles M, Arbos M, Stirbat T, et al.
Oncotarget
. 2018 Apr;
9(24):16648-16664.
PMID: 29682175
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is one of the most important prognostic factors, being directly associated with tumor recurrence and...
7.
Altadill T, Dowdy T, Gill K, Reques A, Menon S, Moiola C, et al.
Sci Rep
. 2017 Aug;
7(1):8803.
PMID: 28821813
Endometrial cancer (EC) remains the most common malignancy of the genital tract among women in developed countries. Although much research has been performed at genomic, transcriptomic and proteomic level, there...
8.
Devis L, Moiola C, Masia N, Martinez-Garcia E, Santacana M, Stirbat T, et al.
J Pathol
. 2016 Nov;
241(4):475-487.
PMID: 27873306
Endometrial cancer is the most common gynaecological cancer in western countries, being the most common subtype of endometrioid tumours. Most patients are diagnosed at an early stage and present an...
9.
De Luca P, Dalton G, Scalise G, Moiola C, Porretti J, Massillo C, et al.
Oncotarget
. 2016 Mar;
7(14):18798-811.
PMID: 26933806
Metabolic syndrome (MeS) has been identified as a risk factor for breast cancer. C-terminal binding protein 1 (CtBP1) is a co-repressor of tumor suppressor genes that is activated by low...
10.
Labanca E, De Luca P, Gueron G, Paez A, Moiola C, Massillo C, et al.
Mol Cancer Res
. 2015 Aug;
13(11):1455-64.
PMID: 26227317
Unlabelled: Prostate cancer is the second leading cause of cancer-related death in men worldwide. Many factors that participate in the development of prostate cancer promote imbalance in the redox state...